[1]
Zalewski, J.Z. et al. 2026. How does the use of GLP-1 receptor agonists affect bone mineral density and fracture risk in obese individuals?. Journal of Education, Health and Sport. 87, (Feb. 2026), 68397. DOI:https://doi.org/10.12775/JEHS.2026.87.68397.